BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38094893)

  • 1. TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter.
    Sun X; Yang L; Sun H; Sun Y; Wei S; Han Y; Wang W; Kong L; Wang X
    Front Pharmacol; 2023; 14():1275974. PubMed ID: 38094893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.
    Liu ZQ; Sun X; Liu ZB; Zhang T; Zhang LL; Wu CJ
    J Pharm Pharmacol; 2022 Jul; 74(7):919-929. PubMed ID: 35640306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
    Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
    Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
    Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
    Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout: epitome of painful arthritis.
    VanItallie TB
    Metabolism; 2010 Oct; 59 Suppl 1():S32-6. PubMed ID: 20837191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and uric acid lowering effects of Euodiae fructus on hyperuricemia and gout mice.
    Wang Z; Liu J; Mou Y; Liao W; Li Y; Liu J; Tang J
    Front Pharmacol; 2024; 15():1296075. PubMed ID: 38708084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches to gout drug discovery: an update.
    Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
    Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout.
    Pérez-Ruiz F; Jansen T; Tausche AK; Juárez-Campo M; Gurunath RK; Richette P
    Drugs Context; 2019; 8():212581. PubMed ID: 31191704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan from
    Zhang Y; Tan X; Lin Z; Li F; Yang C; Zheng H; Li L; Liu H; Shang J
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
    Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
    Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack.
    Zhao T; Cao L; Lin C; Xu R; Du X; Zhou M; Yang X; Wan W; Zou H; Zhu X
    Rheumatology (Oxford); 2023 Dec; 62(12):3984-3992. PubMed ID: 37042723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of hyperuricemia and gout: implications for the present and future.
    George RL; Keenan RT
    Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on gout: Looking back and looking ahead.
    Tao H; Mo Y; Liu W; Wang H
    Int Immunopharmacol; 2023 Apr; 117():109977. PubMed ID: 37012869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of urate.
    Keenan RT
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S2-S10. PubMed ID: 32620198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present).
    Shi X; Zhao T; da Silva-Júnior EF; Zhang J; Xu S; Gao S; Liu X; Zhan P
    Expert Opin Ther Pat; 2022 Dec; 32(12):1175-1184. PubMed ID: 36625031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout.
    Dalbeth N; Gosling AL; Gaffo A; Abhishek A
    Lancet; 2021 May; 397(10287):1843-1855. PubMed ID: 33798500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids Increase Renal Excretion of Urate in Mice by Downregulating Urate Transporter 1.
    Li G; Han L; Ma R; Saeed K; Xiong H; Klaassen CD; Lu Y; Zhang Y
    Drug Metab Dispos; 2019 Nov; 47(11):1343-1351. PubMed ID: 31519697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Effects and Mechanisms of
    Zhang KH; Wang MQ; Wei LL; Feng CJ; Zhang YS; Teng JB
    Evid Based Complement Alternat Med; 2020; 2020():4367347. PubMed ID: 33062010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.